Alex­ion's Hantson poach­es Bio­gen CFO Clan­cy as buzz of a loom­ing pipeline shake­up heats up

You can count one more top ex­ec at Bio­gen $BI­IB out the ex­it as new CEO Michel Vounatsos builds his team at the big biotech. And the de­part­ing ex­ec is head­ed straight to Alex­ion $ALXN, where Lud­wig Hantson has been build­ing his own team with an eye to strip­ping the pipeline ahead of a planned re­fur­bish­ment.

This time the ex­ec on the move is Paul Clan­cy, CFO at Bio­gen dur­ing the last event­ful decade at the big biotech.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.